Feds Fine, Sanction Bridgeport Hospital Following Errors In Testing Specimens

Bridgeport Hospital has been sanctioned and fined $150,000 by the Centers for Medicare & Medicaid Services (CMS) after the hospital erroneously switched eight patient specimens, according to newly released documents. The errors in July 2017 resulted in two patients being given the wrong cancer diagnosis. In one case, a 41-year-old woman had a hysterectomy after being told she had cancer only to learn after the procedure that she did not. The second patient was a 66-year-old who was told that lab results were normal, only to learn later that there was a malignancy present, according to Bridgeport Hospital’s inspection report issued by the state Department of Public Health (DPH). The violations were found when DPH inspectors made unannounced visits to Bridgeport Hospital in July 2018.

Low-Income Diabetics Paying High Price For Insulin

The high cost of insulin, which has risen by triple-digit percentages in the last five years, is endangering the lives of many diabetics who can’t afford the price tag, say Connecticut physicians who treat diabetics. The doctors say that the out-of-pocket costs for insulin, ranging from $25 to upwards of $600 a month, depending on insurance coverage, are forcing many of their low-income patients to choose between treatment and paying their bills. “Some of my patients have to make the choice between rent or insulin,” said Dr. Bismruta Misra, an endocrinologist with the Stamford Health Medical Group. “So they spread out taking insulin [injecting it less frequently than a doctor has prescribed] or don’t take it.”

Experts and recent studies point to drug companies’ long-standing patents and the lack of generic or “biosimilar” insulin as key reasons why the drug is so expensive. A study by Philip Clarke, a professor of health economics at the University of Melbourne in Australia, reported that the price of insulin has tripled from 2002-2013.